1 Unspecified time for visual acuity between 20/20 and 20/40 |
1 |
|
Odds Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
2 Time to resolution of primary hemorrhage (days) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
3 Risk of secondary hemorrhage |
1 |
|
Odds Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
4 Time to rebleed (days) |
|
|
Other data |
No numeric data |
5 Risk of glaucoma or elevated intraocular pressure (IOP) |
1 |
|
Odds Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
6 Adverse effects |
1 |
|
Odds Ratio (M-H, Fixed, 95% CI) |
Totals not selected |
6.1 Nausea or vomiting |
1 |
|
Odds Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
6.2 Dizziness or hypotension |
1 |
|
Odds Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
6.3 Syncope |
1 |
|
Odds Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
6.4 Diarrhea |
1 |
|
Odds Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
6.5 Rash or pruritis |
1 |
|
Odds Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
6.6 Hot flashes |
1 |
|
Odds Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
6.7 Dry mouth or nose |
1 |
|
Odds Ratio (M-H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
7 Duration of hospitalization (days) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |